Cargando…

Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia

Down syndrome (DS) is one of the most frequent genetic abnormalities characterized by multiple pathological phenotypes. Indeed, currently life expectancy and quality of life for DS patients have improved, although with increasing age pathological dysfunctions are exacerbated and intellectual disabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perluigi, Marzia, Butterfield, D. Allan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235450/ https://www.ncbi.nlm.nih.gov/pubmed/22203843 http://dx.doi.org/10.1155/2012/724904

Ejemplares similares

The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
por: Perluigi, Marzia, et al.
Publicado: (2020)

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018)

It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease
por: Tramutola, Antonella, et al.
Publicado: (2016)

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
por: Butterfield, D. Allan, et al.
Publicado: (2020)

Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
por: Di Domenico, Fabio, et al.
Publicado: (2019)

Methionine-35 of Aβ(1–42): Importance for Oxidative Stress in Alzheimer Disease
por: Butterfield, D. Allan, et al.
Publicado: (2011)

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease
por: Butterfield, D. Allan, et al.
Publicado: (2018)

Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and Dementia
por: Coskun, Pinar E., et al.
Publicado: (2012)

Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
por: Tramutola, Antonella, et al.
Publicado: (2023)

Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome
por: Prasher, Vee P, et al.
Publicado: (2016)

Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
por: Butterfield, D. Allan
Publicado: (2023)

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
por: Dierssen, Mara, et al.
Publicado: (2020)

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal‐derived extracellular vesicles
por: Perluigi, Marzia, et al.
Publicado: (2021)

Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study
por: Sultana, Rukhsana, et al.
Publicado: (2007)

Oxidative Stress in HPV-Driven Viral Carcinogenesis: Redox Proteomics Analysis of HPV-16 Dysplastic and Neoplastic Tissues
por: De Marco, Federico, et al.
Publicado: (2012)

The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020)

Effects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approach
por: Perluigi, Marzia, et al.
Publicado: (2010)

Oxidative stress and biomaterials
por: Dziubla, Thomas, et al.
Publicado: (2016)

Oxidative stress, thyroid dysfunction & Down syndrome
por: Campos, Carlos, et al.
Publicado: (2015)

Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview
por: Ferrari, Marta, et al.
Publicado: (2021)

Dementia in Down’s syndrome: an MRI comparison with Alzheimer’s disease in the general population
por: Mullins, Diane, et al.
Publicado: (2013)

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome
por: Jones, Emma L., et al.
Publicado: (2013)

Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
por: Krinsky‐McHale, Sharon J, et al.
Publicado: (2020)

Reporting Down syndrome on the death certificate for Alzheimer disease/unspecified dementia deaths
por: Landes, Scott D., et al.
Publicado: (2023)

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
por: Wilcock, Donna M, et al.
Publicado: (2013)

Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
por: Lanzillotta, Chiara, et al.
Publicado: (2020)

Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome
por: Salem, Lise Cronberg, et al.
Publicado: (2015)

Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain
por: Di Domenico, Fabio, et al.
Publicado: (2013)

Alzheimer’s disease like neuropathology in Down syndrome cortical organoids
por: Zhao, Helen H., et al.
Publicado: (2022)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

MTRNR2L12: A Candidate Blood Marker of Early Alzheimer’s Disease-Like Dementia in Adults with Down Syndrome
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2015)

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome()
por: Mok, Kin Y., et al.
Publicado: (2014)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
por: Benejam, Bessy, et al.
Publicado: (2020)

Editorial: Down Syndrome, Neurodegeneration and Dementia
por: Mufson, Elliott J., et al.
Publicado: (2021)

β-Secretases, Alzheimer's Disease, and Down Syndrome
por: Webb, Robin L., et al.
Publicado: (2012)

Role of neuroimaging in multidisciplinary approach towards Non-Alzheimer’s dementia
por: Patro, Satya Narayana, et al.
Publicado: (2015)

A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Lee, Ni-Chung, et al.
Publicado: (2017)

Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation
por: Ton, Alyne Mendonça Marques, et al.
Publicado: (2020)

Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53
por: Fiorini, Ada, et al.
Publicado: (2012)

Copper Nanoparticles for Printed Electronics: Routes Towards Achieving Oxidation Stability
por: Magdassi, Shlomo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e76illfonb8enhfq4fapaolc4s